NCT00145613 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00145613/arm-group/c4ca4238a0b923820dcc509a6f75849b]
Systemic chemotherapy and antibodies [clinicaltrials_resource:89466cc6338434654ec95ea1d157a6ea]Stem Cell Transplantation [clinicaltrials_resource:b8e592b0f07ae730df59e6883fdec503]Miltenyi Biotec CliniMACS [clinicaltrials_resource:ef200efea081806364b01bf94314aada]Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies [clinicaltrials:NCT00145613]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00145613 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00145613/arm-group/c4ca4238a0b923820dcc509a6f75849b]
Bio2RDF identifier
NCT00145613/arm-group/c4ca4238a0b923820dcc509a6f75849b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ca4238a0b923820dcc509a6f75849b
identifier
clinicaltrials_resource:NCT00145613/arm-group/c4ca4238a0b923820dcc509a6f75849b
title
NCT00145613 arm group c4ca4238a0b923820dcc509a6f75849b
@en
type
label
NCT00145613 arm group c4ca4238 ...... a4238a0b923820dcc509a6f75849b]
@en